The Therapeutic Monoclonal Antibody Bamlanivimab Does Not Enhance SARS-CoV-2 Infection by FcR-Mediated Mechanisms.

Autor: Cross RW; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX 77555, USA., Wiethoff CM; Eli Lilly and Company, Indianapolis, IN 46285, USA., Brown-Augsburger P; Eli Lilly and Company, Indianapolis, IN 46285, USA., Berens S; Eli Lilly and Company, Indianapolis, IN 46285, USA., Blackbourne J; Eli Lilly and Company, Indianapolis, IN 46285, USA., Liu L; Eli Lilly and Company, Indianapolis, IN 46285, USA., Wu X; Eli Lilly and Company, Indianapolis, IN 46285, USA., Tetreault J; Eli Lilly and Company, Indianapolis, IN 46285, USA., Dodd C; Eli Lilly and Company, Indianapolis, IN 46285, USA., Sina R; Eli Lilly and Company, Indianapolis, IN 46285, USA., Witcher DR; Eli Lilly and Company, Indianapolis, IN 46285, USA., Newcomb D; Charles River Laboratories, Inc., Reno, NV 89511, USA., Frost D; Charles River Laboratories, Inc., Reno, NV 89511, USA., Wilcox A; Charles River Laboratories, Inc., Reno, NV 89511, USA., Borisevich V; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX 77555, USA., Agans KN; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX 77555, USA., Woolsey C; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX 77555, USA., Prasad AN; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX 77555, USA., Deer DJ; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX 77555, USA., Geisbert JB; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX 77555, USA., Dobias NS; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX 77555, USA., Fenton KA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX 77555, USA., Strifler B; Eli Lilly and Company, Indianapolis, IN 46285, USA., Ebert P; Eli Lilly and Company, Indianapolis, IN 46285, USA., Higgs R; Eli Lilly and Company, Indianapolis, IN 46285, USA., Beall A; Immunity and Pathogenesis Program, Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA., Chanda S; Department of Immunology and Microbiology, Scripps Research, La Jolla, CA 92037, USA., Riva L; Immunity and Pathogenesis Program, Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA., Yin X; Immunity and Pathogenesis Program, Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA., Geisbert TW; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX 77555, USA.

Publikováno v: Pathogens (Basel, Switzerland) [Pathogens] 2023 Nov 30; Vol. 12 (12). Date of Electronic Publication: 2023 Nov 30.

Actions of serotonergic agents on hypothalamic-pituitary-adrenal axis activity in the rat

Autor: Matheson, G. K., Knowles, A., Guthrie, D., Gage, D., Weinzapfel, D., Blackbourne, J.

Publikováno v: General Pharmacology: The Vascular System (now called Vascular Pharmacology); 1997, Vol. 29 Issue: 5 p823-828, 6p

Лікування вибухових ран кінцівок з використанням негативного тиску

Autor: Вирва, О. Є.¹ dr.olegvyrva@gmail.com, Міхановський, Д. О.¹ dmitriy.mikhanovskiy@gmail.com, Бець, І. Г.¹ betsirina1984@gmai.com, Біцадзе, М. З.¹ bitsadze85@gmail.com, Шевченко, І. В.¹ shevchenkoigor76@gmail.com, Рикун, М. Д.¹ riggenkiy@gmail.com, Скіданов, М. А.¹ skidanov.doc@gmail.com

Publikováno v: Orthopaedics, Traumatology & Prosthetics / Ortopediia, Traumatologiia i Protezirovaniie. 2022, Issue 3/4, p5-12. 8p.

Lack of efficacy of mono‐mode of action therapeutics in COVID‐19 therapy ‐ How the lack of predictive power of preclinical cell and animal studies leads developments astray.

Autor: Haberland, Annekathrin¹ (AUTHOR) haberland@berlincures.de, Müller, Johannes¹ (AUTHOR)

Publikováno v: Chemical Biology & Drug Design. Jan2022, Vol. 99 Issue 1, p32-45. 14p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.